相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The Possible Neuroprotective Effect of Silymarin against Aluminum Chloride-Prompted Alzheimer's-Like Disease in Rats
Hanaa R. Aboelwafa et al.
BRAIN SCIENCES (2020)
Immunoregulatory Effects of Silymarin on Proliferation and Activation of Th1 Cells Isolated from Newly Diagnosed and IFN-ß1b-Treated MS Patients
Fereshteh Navabi et al.
INFLAMMATION (2019)
Abnormal effector and regulatory T cell subsets in paediatric-onset multiple sclerosis
Ina Mexhitaj et al.
BRAIN (2019)
Silymarin Restores Regulatory T Cells (Tregs) Function in Multiple Sclerosis (MS) Patients In Vitro
Maryam Shariati et al.
INFLAMMATION (2019)
Effector T Cells in Multiple Sclerosis
Belinda J. Kaskow et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
Promising effect of rapamycin on multiple sclerosis
Bahram Bagherpour et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2018)
The Natural Agonist of Estrogen Receptor β Silibinin Plays an Immunosuppressive Role Representing a Potential Therapeutic Tool in Rheumatoid Arthritis
Maria Luisa Dupuis et al.
FRONTIERS IN IMMUNOLOGY (2018)
Differential regulation of CD4(+) T cell subsets by Silymarin in vitro and in ovalbumin immunized mice
Haideh Namdari et al.
DARU-JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Silymarin impacts on immune system as an immunomodulator: One key for many locks
Nafiseh Esmaeil et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
Regulatory T cells in multiple sclerosis and myasthenia gravis
K. M. Danikowski et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Determination of cytokine levels in multiple sclerosis patients and their relevance with patients' response to Cinnovex
Mohammad Taheri et al.
CYTOKINE (2017)
Oxidative stress in multiple sclerosis: Central and peripheral mode of action
Kim Ohl et al.
EXPERIMENTAL NEUROLOGY (2016)
Presentation and Outcomes with Clinically Apparent Interferon Beta Hepatotoxicity
Robert J. Fontana et al.
DIGESTIVE DISEASES AND SCIENCES (2013)
Silymarin in non alcoholic fatty liver disease
Fulvio Cacciapuoti et al.
WORLD JOURNAL OF HEPATOLOGY (2013)
Dimethyl Fumarate Inhibits Dendritic Cell Maturation via Nuclear Factor κB (NF-κB) and Extracellular Signal-regulated Kinase 1 and 2 (ERK1/2) and Mitogen Stress-activated Kinase 1 (MSK1) Signaling
Haiyan Peng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
IL-27 mediates the response to IFN-β therapy in multiple sclerosis patients by inhibiting Th17 cells
Cheryl M. Sweeney et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis
Robert C. Axtell et al.
NATURE MEDICINE (2010)
Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis
M. Mehling et al.
NEUROLOGY (2010)
T-Helper 17 Cells Expand in Multiple Sclerosis and Are Inhibited by Interferon-β
Luca Durelli et al.
ANNALS OF NEUROLOGY (2009)
IFN-β Inhibits Human Th17 Cell Differentiation
Vinod S. Ramgolam et al.
JOURNAL OF IMMUNOLOGY (2009)
Immunosuppressive effect of silibinin in experimental autoimmune encephalomyelitis
Kyungwon Min et al.
ARCHIVES OF PHARMACAL RESEARCH (2007)
The relation between intracranial and intraocular pressures: Study of 50 patients - Reply
CH Polman et al.
ANNALS OF NEUROLOGY (2006)
Medical progress: Multiple sclerosis - The plaque and its pathogenesis
EM Frohman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Treatment of alcoholic liver disease
I Bergheim et al.
DIGESTIVE DISEASES (2005)
Liver injury associated with the β-interferons for MS
EM Wallack et al.
NEUROLOGY (2004)
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand
B Bielekova et al.
NATURE MEDICINE (2000)